Great Lakes Advisors, LLC Edwards Lifesciences Corp Transaction History

Great Lakes Advisors, LLC

$11.1 Billion
Q3 2024

A detailed history of Great Lakes Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 5,085 shares of EW stock, worth $370,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,085

Previous 5,358 5.1%

Holding current value

$370,238

Previous $494,000 32.19%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$59.7 - $93.78 $16,298 - $25,601	-273 Reduced 5.1%	5,085 $335,000
Q2 2024 Aug 05, 2024	SELL	$84.3 - $94.31 $250,539 - $280,289	-2,972 Reduced 35.68%	5,358 $494,000
Q1 2024 May 08, 2024	SELL	$72.54 - $95.56 $422,182 - $556,159	-5,820 Reduced 41.13%	8,330 $796,000
Q4 2023 Feb 08, 2024	BUY	$61.71 - $77.76 $37,704 - $47,511	611 Added 4.51%	14,150 $1.08 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $1.84 Million - $2.48 Million	-26,600 Reduced 66.27%	13,539 $937,000
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $597,630 - $692,476	7,341 Added 22.38%	40,139 $3.79 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $102,553 - $116,708	-1,381 Reduced 4.04%	32,798 $2.71 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $19,328 - $24,745	-283 Reduced 0.82%	34,179 $2.55 Million
Q3 2022 Nov 09, 2022	SELL	$82.37 - $107.29 $339,776 - $442,571	-4,125 Reduced 10.69%	34,462 $2.85 Million
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $261,143 - $387,247	-3,019 Reduced 7.26%	38,587 $3.67 Million
Q1 2022 May 06, 2022	SELL	$101.96 - $128.34 $262,139 - $329,962	-2,571 Reduced 5.82%	41,606 $4.9 Million
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $5.06 Million - $6.22 Million	-47,604 Reduced 51.87%	44,177 $5.72 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $2.83 Million - $3.37 Million	27,494 Added 42.77%	91,781 $10.4 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $1.85 Million - $2.31 Million	22,064 Added 52.26%	64,287 $6.66 Million
Q1 2021 May 03, 2021	SELL	$78.68 - $90.67 $110,545 - $127,391	-1,405 Reduced 3.22%	42,223 $3.53 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $124,668 - $158,648	1,739 Added 4.15%	43,628 $3.98 Million
Q3 2020 Nov 04, 2020	SELL	$67.19 - $87.44 $51,736 - $67,328	-770 Reduced 1.81%	41,889 $3.34 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.66 Million - $2.22 Million	28,892 Added 209.86%	42,659 $2.95 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $79,768 - $123,282	1,522 Added 12.43%	13,767 $2.6 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $108,123 - $123,791	-1,508 Reduced 10.96%	12,245 $2.86 Million
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $23,819 - $29,191	387 Added 2.9%	13,753 $3.02 Million
Q2 2019 Aug 05, 2019	SELL	$55.74 - $64.41 $16,164 - $18,678	-290 Reduced 2.12%	13,366 $2.47 Million
Q1 2019 May 07, 2019	SELL	$47.89 - $64.05 $127,531 - $170,565	-2,663 Reduced 16.32%	13,656 $2.61 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $979,715 - $1.2 Million	-21,110 Reduced 56.4%	16,319 $2.5 Million
Q3 2018 Nov 30, 2018	BUY	$45.7 - $58.03 $1.63 Million - $2.08 Million	35,769 Added 2154.76%	37,429 $6.52 Million
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $1.91 Million - $2.42 Million	-41,769 Reduced 96.18%	1,660 $289,000
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $623,505 - $753,494	14,688 Added 51.1%	43,429 $6.32 Million
Q1 2018 May 07, 2018	BUY	$37.19 - $47.45 $463,945 - $591,938	12,475 Added 76.69%	28,741 $4.01 Million
Q4 2017 Feb 08, 2018	SELL	$33.79 - $39.39 $155,197 - $180,918	-4,593 Reduced 22.02%	16,266 $1.83 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $756,973 - $809,954	20,859	20,859 $2.28 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account

Great Lakes Advisors, LLC Edwards Lifesciences Corp Transaction History